GlaxoSmithKline yesterday stepped up its expansion into emerging markets, striking an alliance to sell more than 100 drugs of Dr Reddy's, the Indian generic pharmaceuticals maker, in Africa, the Middle East, the Asia Pacific and Latin America.
葛兰素史克(GSK)昨日加快其进军新兴市场的步伐，该公司与印度非专利药品制造商Dr Reddy's结盟，将在非洲、中东、亚太及拉美地区销售后者生产的100多种药品。
您已阅读10%（325字），剩余90%（3017字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。